Lineage Cell Therapeutics, Inc.·4

Jul 1, 4:21 PM ET

Cook Kevin Leon 4

4 · Lineage Cell Therapeutics, Inc. · Filed Jul 1, 2021

Insider Transaction Report

Form 4
Period: 2021-06-21
Cook Kevin Leon
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-06-21+750,000750,000 total
    Exercise: $2.68Exp: 2031-06-20Common Shares (750,000 underlying)
Footnotes (1)
  • [F1]This option will vest as to one quarter of the shares subject to the option on June 21, 2022, and the balance will vest in 36 successive substantially equal monthly installments thereafter, subject to the reporting person's continuous employment.

Documents

1 file
  • 4
    ownership.xmlPrimary